爱尔兰2023年对Covid-19疫苗的负面反应报告为5%,低于2022年的26%;抗乳粉药物占报告总数的多数。 5% of adverse reaction reports in Ireland 2023 for Covid-19 vaccines, down from 26% in 2022; antineoplastic medicines dominate total reports.

Covid-19疫苗占爱尔兰2023年药物不良反应报告的5%,低于2022年的26%,据报有400起事件。 Covid-19 vaccines made up 5% of adverse reaction reports to medicines in Ireland in 2023, down from 26% in 2022, with 400 incidents reported. 用于癌症治疗的抗塑胶药物占不良反应报告的大多数。 Antineoplastic medicines, used in cancer treatment, accounted for the majority of adverse reaction reports. 卫生产品管制局继续密切监测可疑副作用,特别是造成致命后果的副作用。 The Health Products Regulatory Authority (HPRA) continues to closely monitor suspected side effects, particularly those resulting in fatal outcomes.